1. Home
  2. ZLAB vs HAYW Comparison

ZLAB vs HAYW Comparison

Compare ZLAB & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • HAYW
  • Stock Information
  • Founded
  • ZLAB 2013
  • HAYW 1925
  • Country
  • ZLAB China
  • HAYW United States
  • Employees
  • ZLAB N/A
  • HAYW N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • HAYW Electronic Components
  • Sector
  • ZLAB Health Care
  • HAYW Technology
  • Exchange
  • ZLAB Nasdaq
  • HAYW Nasdaq
  • Market Cap
  • ZLAB 3.2B
  • HAYW 3.3B
  • IPO Year
  • ZLAB 2017
  • HAYW 2021
  • Fundamental
  • Price
  • ZLAB $26.35
  • HAYW $15.59
  • Analyst Decision
  • ZLAB Buy
  • HAYW Hold
  • Analyst Count
  • ZLAB 6
  • HAYW 5
  • Target Price
  • ZLAB $57.22
  • HAYW $17.33
  • AVG Volume (30 Days)
  • ZLAB 613.7K
  • HAYW 1.5M
  • Earning Date
  • ZLAB 11-06-2025
  • HAYW 10-29-2025
  • Dividend Yield
  • ZLAB N/A
  • HAYW N/A
  • EPS Growth
  • ZLAB N/A
  • HAYW 46.31
  • EPS
  • ZLAB N/A
  • HAYW 0.60
  • Revenue
  • ZLAB $427,799,000.00
  • HAYW $1,083,088,000.00
  • Revenue This Year
  • ZLAB $41.80
  • HAYW $5.84
  • Revenue Next Year
  • ZLAB $49.93
  • HAYW $5.39
  • P/E Ratio
  • ZLAB N/A
  • HAYW $25.96
  • Revenue Growth
  • ZLAB 32.56
  • HAYW 8.77
  • 52 Week Low
  • ZLAB $23.82
  • HAYW $11.10
  • 52 Week High
  • ZLAB $44.34
  • HAYW $16.87
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 30.35
  • HAYW 54.33
  • Support Level
  • ZLAB $26.07
  • HAYW $14.93
  • Resistance Level
  • ZLAB $29.77
  • HAYW $15.78
  • Average True Range (ATR)
  • ZLAB 1.21
  • HAYW 0.40
  • MACD
  • ZLAB -0.41
  • HAYW 0.04
  • Stochastic Oscillator
  • ZLAB 3.54
  • HAYW 80.21

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About HAYW Hayward Holdings Inc.

Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.

Share on Social Networks: